Suchergebnisse - "Rice, Todd W"

PubPharm (13)

1

Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Tenforde, M. | Self, W. | Zhu, Y. | +58

2

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years - IVY Network, 18 States, September 8-November 30, 2022

enthalten in: MMWR. Morbidity and mortality weekly report | 2022

von Surie, D. | DeCuir, J. | Zhu, Y. | +47

3

Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States

enthalten in: Vaccine | 2022

von Turbyfill, C. | Adams, K. | Tenforde, M. | +51

4

Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022

enthalten in: MMWR. Morbidity and mortality weekly report | 2022

von Surie, D. | Bonnell, L. | Adams, K. | +151

5

Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Lewis, N. | Self, W. | Gaglani, M. | +54

6

Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021

enthalten in: The Journal of infectious diseases | 2022

von Lewis, N. | Naioti, E. | Self, W. | +155

7

Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Tenforde, M. | Patel, M. | Ginde, A. | +56

UpdateOf: medRxiv. 2021 Jul 08;:. - PMID 34268515

8

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States : prospective observational study

enthalten in: BMJ (Clinical research ed.) | 2022

von Lauring, A. | Tenforde, M. | Chappell, J. | +57

UpdateOf: medRxiv. 2022 Feb 07;:. - PMID 35169811

9

Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity

enthalten in: JAMA | 2021

von Tenforde, M. | Self, W. | Adams, K. | +56

CommentIn: JAMA. 2021 Nov 23;326(20):2018-2020. - PMID 34734985

10

Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021

enthalten in: MMWR. Morbidity and mortality weekly report | 2021

von Self, W. | Tenforde, M. | Rhoads, J. | +157